IMCR
Immunocore Holdings Ltd
29.60$
-0.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
Immunocore Holdings Ltd (IMCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -5.5 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18 | -18 | -39 | -26 | -31 | -10 | 0.6 | -21 | -26 | -33 | -21 | -16 | -31 | -9.2 | 8.1 | 7.9 | 8.5 | 0.0 | 7.8 | -13 | -4.6 | 23 | 21 | -14 | 0.4 | 26 | -4.5 | -33 | -14 | -5.5 | -56 | |
| 2.4 | 2.4 | 2.1 | 2.3 | 2.2 | 2.3 | 2.2 | 2.5 | 1.8 | 1.8 | 1.7 | 1.7 | 1.7 | 1.6 | 1.5 | 1.6 | 0.8 | 0.8 | 1.4 | 0.2 | 1.0 | 1.0 | 1.0 | 1.2 | 0.9 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 3.6 | |
| 0.7 | 0.7 | 1.1 | 0.6 | 0.2 | 3.2 | 1.8 | 3.0 | 8.6 | 9.3 | 9.2 | 8.7 | 7.4 | 6.7 | 6.1 | 6.9 | 6.7 | 6.8 | 8.2 | 15 | 9.0 | 10 | 6.6 | 8.7 | 9.5 | 10 | 9.8 | 8.3 | 6.3 | 16 | 40 | |
| – | – | – | -4.8 | -12 | 8.0 | 18 | -0.7 | 3.1 | 10 | 9.4 | 23 | 8.0 | -4.1 | -6.1 | 24 | 8.5 | 8.5 | -2.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -5.7 | -5.7 | -7.2 | -1.4 | -13 | -12 | -0.6 | -5.7 | -4.4 | -9.0 | -2.1 | -1.4 | -24 | -8.6 | 6.5 | 7.5 | 11 | 2.0 | 4.7 | -4.5 | 8.1 | 27 | -35 | -8.2 | -7.6 | 27 | -1.3 | -20 | -30 | 8.5 | -43 | |
| 0.7 | 0.7 | 1.1 | 1.6 | 1.4 | 0.6 | 0.7 | 0.3 | 0.2 | 0.1 | 0.4 | 0.3 | 0.1 | 0.3 | 0.4 | 1.1 | 2.4 | 1.1 | 0.6 | 0.6 | 0.4 | 0.3 | 0.8 | 3.6 | 0.3 | 0.4 | 0.7 | 2.9 | 1.8 | 0.8 | 6.2 | |
| -0.8 | -0.8 | -1.0 | -1.6 | -1.3 | -0.4 | 0.3 | 1.8 | 0.0 | 0.0 | -0.1 | -0.3 | -0.1 | -0.2 | 0.2 | 0.4 | -2.4 | -1.1 | -1.8 | 0.6 | -0.4 | -350 | -0.8 | -3.5 | 9.7 | -30 | 5.3 | -0.9 | 4.2 | -0.8 | 7.8 | |
| – | – | – | – | 0.0 | 0.0 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -1.0 | -1.1 | -1.1 | -1.1 | 36 | -0.8 | -1.6 | -0.9 | -0.7 | -0.8 | -0.7 | -0.8 | -0.9 | -0.4 | -0.4 | -0.3 | – | – | – | 0.0 | -50 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | |
| -1.0 | -1.0 | 58 | -1.0 | 26 | -1.1 | -1.1 | 92 | 209 | -1.6 | -1.1 | -2.1 | -1.3 | -0.5 | 118 | -9.5 | 5.0 | 9.2 | 8.4 | 6.1 | 396 | -0.5 | 0.2 | -52 | 2.6 | 3.7 | 1.9 | 4.3 | 0.7 | 16 | 23 | |
| – | 85 | 18 | -28 | -5.6 | -12 | -0.1 | 73 | 183 | -34 | -22 | -19 | -32 | 2.2 | 139 | 12 | 13 | 14 | 7.4 | -1.3 | 390 | -328 | 33 | -82 | 21 | 11 | 10 | -31 | -15 | 16 | -20 | |
| -19 | -19 | -41 | -27 | -32 | -11 | 0.0 | -21 | -26 | -33 | -22 | -17 | -31 | -9.5 | 7.7 | 6.9 | 6.1 | -1.1 | 7.2 | -14 | -5.0 | 23 | 20 | -18 | 0.1 | 26 | -5.2 | -36 | -16 | -6.3 | -63 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.